+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fusilev"

Fusilev - API Insight, 2022 - Product Thumbnail Image

Fusilev - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Fusilev- Drug Insight, 2019 - Product Thumbnail Image

Fusilev- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Fusilev is a brand of chemotherapy drug used to treat colorectal cancer. It is a folate analog, meaning it is a synthetic form of the vitamin folic acid. Fusilev works by blocking the action of an enzyme called dihydrofolate reductase, which is necessary for the growth of cancer cells. This prevents the cancer cells from dividing and growing, ultimately leading to their death. Fusilev is typically used in combination with other chemotherapy drugs, such as 5-fluorouracil, to increase its effectiveness. The Fusilev market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are responsible for the research and development of the drug, as well as its production and marketing. They also provide support services to healthcare providers and patients, such as patient education and access to financial assistance programs. Some companies in the Fusilev market include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more